Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
Pragmatica-Lung, a landmark pragmatic trial with registrational intent, starts enrollment

Pragmatica-Lung, a landmark pragmatic trial with registrational intent, starts enrollment

April 14, 2023
Vol.49 No.15
By Jacquelyn Cobb
NCI Director Bertagnolli designs Cancer Plan to trigger national conversation, transform cancer research and care
NCI

NCI Director Bertagnolli designs Cancer Plan to trigger national conversation, transform cancer research and care

April 07, 2023
Vol.49 No.14
By Matthew Bin Han Ong
ACT for NIH publishes Mary Lasker biography to use in lobbying for appropriations—Mary would’ve approved
Cancer History ProjectFree

ACT for NIH publishes Mary Lasker biography to use in lobbying for appropriations—Mary would’ve approved

March 24, 2023
Vol.49 No.12
By Paul Goldberg
Jed Manocherian grew obsessed with Mary Lasker after starting an NIH lobbying organization
Cancer History ProjectConversation with The Cancer LetterFree

Jed Manocherian grew obsessed with Mary Lasker after starting an NIH lobbying organization

March 24, 2023
Vol.49 No.12
By Paul Goldberg
Lasker Foundation’s Claire Pomeroy: “Mary’s story truly has been an untold story”
Cancer History ProjectConversation with The Cancer LetterFree

Lasker Foundation’s Claire Pomeroy: “Mary’s story truly has been an untold story”

March 24, 2023
Vol.49 No.12
By Paul Goldberg
Bertagnolli to announce National Cancer Plan that would “align broad societal engagement” to reduce cancer mortality
NCI

Bertagnolli to announce National Cancer Plan that would “align broad societal engagement” to reduce cancer mortality

March 24, 2023
Vol.49 No.12
By Matthew Bin Han Ong
Does salpingectomy prevent ovarian cancer? Let’s prove it.
Trials & Tribulations

Does salpingectomy prevent ovarian cancer? Let’s prove it.
The SOROCk clinical trial, NRG CC008 (NCT04251052)

March 17, 2023
Vol.49 No.11
By Kathryn P. Pennington, Warner K. Huh, Sandra Russo and Joan L. Walker
Biden requests $503M increase for NCI, new funds for the Moonshot, $1B for ARPA-H in FY24
White House

Biden requests $503M increase for NCI, new funds for the Moonshot, $1B for ARPA-H in FY24

March 10, 2023
Vol.49 No.10
By Matthew Bin Han Ong
Funding Opportunities

Cancer Grand Challenges announces global research funding opportunity with nine new challenges

March 10, 2023
Vol.49 No.10
Clinical Roundup

NCI Center for Cancer Research study identifies ecDNA as driver of SCLC

March 10, 2023
Vol.49 No.10

Posts navigation

Previous1…262728…39Next

Trending Stories

  • Pour a Scotch, we’re talking clinical trials and prediction markets
  • Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
  • Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
  • Prediction markets now allow betting on clinical trial results, FDA decisions
    It’s a high-risk bet: Insider trading, equipoise, integrity of research, public trust are at stake
  • Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
    “There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns
  • Is it time to re-assess the practice and practicality of screening colonoscopy?
    Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account